Hypertrophic Cardiomyopathy and Other Causes of Sudden Cardiac Death in Young Competitive Athletes, with Considerations for Preparticipation Screening and Criteria for Disqualification

Cardiology Clinics

Volumn 25, Issue 3, 2007, Pages 399-414

  Maron, Barry J ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; BRAIN CONCUSSION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CORONARY ARTERY ANOMALY; GENETIC SCREENING; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SCREENING TEST; SPORT; SUDDEN DEATH;

AGE FACTORS; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; MASS SCREENING; RISK ASSESSMENT; SPORTS MEDICINE; SURVIVAL RATE; WORLD HEALTH;

EID: 35349008583     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2007.07.006     Document Type: Review

References (69)

1. Maron B.J. Sudden death in young athletes: lessons from the hank gathers affair. N Engl J Med 329 (1993) 55-57
2. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athletes: clinical, demographic and pathological profiles. JAMA 276 (1996) 199-204
3. Maron B.J., Mitten M.J., Quandt E.K., et al. Competitive athletes with cardiovascular disease-the case of Nicholas Knapp. N Engl J Med 339 (1998) 1623-1625
4. Maron B.J. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 129 (1998) 379-386
5. Van Camp S.P., Bloor C.M., Mueller F.O., et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 27 (1995) 641-647
6. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
7. Maron B.J., Carney K.P., Lever H.M., et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 41 (2003) 974-980
8. Maron B.J., Doerer J.J., Haas T.S., et al. Profile and frequency of sudden deaths in 1,463 young competitive athletes: from a 25-year US national registry, 1980-2005. Circulation 114 Suppl II (2006) II-830
9. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
10. Maron B.J., Epstein S.E., and Roberts W.C. Causes of sudden death in the competitive athlete. J Am Coll Cardiol 7 (1986) 204-214
11. Corrado D., Basso C., Pavei A., et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA (2006) 1593-1601
12. Maron B.J., and Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports including sudden death. Circulation 114 (2006) 1633-1644
13. Maron B.J., Roberts W.C., McAllister H.A., et al. Sudden death in young athletes. Circulation 62 (1980) 218-229
14. Maron B.J., Poliac L.V., Kaplan J.A., et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 33 (1995) 337-342
15. Maron B.J., Gohman T.E., Kyle S.B., et al. Clinical profile and spectrum of commotio cordis. JAMA 287 (2002) 1142-1146
16. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 115 (2007) 1643-1655
17. Corrado D., Pelliccia A., Björnstad H.H., et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26 (2005) 510-524
18. Maron B.J., and Zipes D.P. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45 (2005) 1312-1375
19. Pelliccia A., Fagard R., Björnstad H.H., et al. A European Society of Cardiology consensus document: recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J 26 (2005) 1422-1445
20. Maron B.J. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7 (1986) 190-203
21. Pelliccia A., Maron B.J., Spataro A., et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324 (1991) 295-301
22. Pelliccia A., Maron B.J., Culasso F., et al. Athlete's heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA 276 (1996) 211-215
23. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
24. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 42 (2003) 1687-1713
25. Maron B.J., Gardin J.M., Flack J.M., et al. Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92 (1995) 785-789
26. Seidman J.G., and Seidman C.E. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
27. Arad M., Maron B.J., Gorham J.M., et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352 (2005) 362-372
28. Spirito P., Seidman C.E., McKenna W.J., et al. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
29. Maron B.J., and Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
30. Maron M.S., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
31. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
32. Rickers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
33. Maron B.J., Gross B.W., and Stark S.I. Extreme left ventricular hypertrophy. Circulation 92 (1995) 3748
34. Spirito P., Bellone P., Harris K.M., et al. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
35. Maron B.J., Pelliccia A., and Spirito P. Cardiac disease in young trained athletes: Insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 91 (1995) 1596-1601
36. Charron P., Dubourg O., Desnos M., et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96 (1997) 214-219
37. Roberts W.C. Congenital coronary arterial anomalies unassociated with major anomalies of the heart or great vessels. In: Roberts W.C. (Ed). Adult congenital heart disease (1987), FA Davis Co, Philadelphia 583-629
38. Basso C., Maron B.J., Corrado D., et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. Circulation 53 (1976) 122-131
39. Maron B.J., Leon M.B., Swain J.A., et al. Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of valsalva. Am J Cardiol 68 (1991) 140-142
40. Jureidini S.B., Eaton C., Williams J., et al. Transthoracic two-dimensional and color flow echocardiographic diagnosis of aberrant left coronary artery. Am Heart J 127 (1994) 438-440
41. Thiene G., Nava A., Corrado D., et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318 (1988) 129-133
42. McKenna W.J., Thiene G., Nava A., et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71 (1994) 215-218
43. Corrado D., Basso C., Rizzoli G., et al. Does sport activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003) 1964-1966
44. Daliento L., Turrini P., Nava A., et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol 25 (1995) 655-664
45. Corrado D., Basso C., Thiene G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30 (1997) 1512-1520
46. Pelliccia A., and Maron B.J. Preparticipation cardiovascular evaluation of the competitive athlete: Perspectives from the 30-year Italian experience. Am J Cardiol 75 (1995) 827-828
47. Corrado D., Basso C., Schiavon M., et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 (1998) 364-369
48. Bharti S., and Lev M. Congenital abnormalities of the conduction system in sudden death in young adults. J Am Coll Cardiol 8 (1986) 1096-1104
49. Schwarz E.R., Klues H.G., vom Dahl J., et al. Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol 27 (1996) 1637-1645
50. Lange R.A., and Hillis L.D. Cardiovascular complications of cocaine use. N Engl J Med 345 (2001) 351-358
51. Samenuk D., Link M.S., Homoud M.K., et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 77 (2002) 12-16
52. Estes III N.A.M., Kloner R., Olshansky B., et al. Drugs and performance-enhancing substances. In, 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities (BJ Maron and DP Zipes). J Am Coll Cardiol 45 (2005) 1368-1369
53. Link M.S., Wang P.J., Pandian N.G., et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 338 (1998) 1805-1811
54. Link M.S., Maron B.J., Garan A.R., et al. Impact object shape and resultant left ventricular pressure critically important in the generation of ventricular fibrillation from chest wall impact (commotio cordis). [abstract]. J Am Coll Cardiol 49 Suppl A (2007) 16A
55. Link M.S., Maron B.J., Song C.P., et al. Evidence for mechanically-induced ion-channel dysfunction as a mechanism in chest blow-induced ventricular fibrillation (commotio cordis). [abstract]. J Am Coll Cardiol 49 Suppl A (2007) 7A
56. ATP channel is a mechanism by which sudden death is produced by low energy chest wall impact (commotio cordis). Circulation 100 (1999) 413-418
57. Weinstock J., Maron B.J., Song C., et al. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 117 (2006) e656-e662 [1404-5]
58. Maron B.J., Gohman T.E., and Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 32 (1998) 1881-1884
59. Maron B.J., Poliac L.C., and Roberts W.O. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 28 (1996) 428-431
60. Roberts W.O., and Maron B.J. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 46 (2005) 1373-1374
61. Maron B.J., Shen W.-K., Link M.S., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
62. Maron B.J., Spirito P., Shen W.-K., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertropic cardiomyopathy. JAMA 298 (2007) 405-412
63. Glover D.W., and Maron B.J. Profile of preparticipation cardiovascular screening for high school athletes. JAMA 279 (1998) 1817-1819
64. Pfister G.C., Puffer J.C., and Maron B.J. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA 283 (2000) 1597-1599
65. Glover DW, Glover DW, Maron BJ. Evolution in the process of screening U.S. high school student-athletes for cardiovascualr disease. America Journal of Cardiology, in press.
66. Montgomery J.V., Harris K.M., Casey S.A., et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96 (2005) 270-275
67. Maron B.J., Spirito P., Wesley Y.E., et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 315 (1986) 610-614
68. Maron B.J., and Klues H.G. Surviving competitive athletics with hypertrophic cardiomyopathy. Am J Cardiol 73 (1994) 1098-1104
69. Paterick T.E., Paterick T.J., Fletcher G.F., et al. Medical and legal issues impacting the cardiovascular evaluation of competitive athletes. JAMA 294 (2005) 3011-3018